202 related articles for article (PubMed ID: 19442104)
1. A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman.
Gallelli L; Spagnuolo V; Palleria C; De Sarro G; Ferraro M
Curr Drug Saf; 2009 May; 4(2):119-20. PubMed ID: 19442104
[TBL] [Abstract][Full Text] [Related]
2. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
Khouri C; Planès S; Logerot S; Villier C; Mallaret M
Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
[TBL] [Abstract][Full Text] [Related]
3. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
Meterissian GB
Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
[TBL] [Abstract][Full Text] [Related]
4. Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents.
Zalsman G; Lewis R; Konas S; Loebstein O; Goldberg P; Burguillo F; Nahshoni E; Munitz H
Int J Adolesc Med Health; 2004; 16(2):179-82. PubMed ID: 15266995
[TBL] [Abstract][Full Text] [Related]
5. Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies.
Sechi G; Agnetti V; Masuri R; Deiana GA; Pugliatti M; Paulus KS; Rosati G
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug; 24(6):1043-51. PubMed ID: 11041543
[TBL] [Abstract][Full Text] [Related]
6. Risperidone and NMS?
Murray S; Haller E
Psychiatr Serv; 1995 Sep; 46(9):951. PubMed ID: 7583513
[No Abstract] [Full Text] [Related]
7. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
Liu PY; Wu PC; Chen CY; Chen YC
Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic malignant syndrome with risperidone.
Levin GM; Lazowick AL; Powell HS
J Clin Psychopharmacol; 1996 Apr; 16(2):192-3. PubMed ID: 8690838
[No Abstract] [Full Text] [Related]
9. Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
Reeves RR; Mack JE; Torres RA
Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988
[TBL] [Abstract][Full Text] [Related]
10. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?
Cherry S; Siskind D; Spivak V; Wysoczanski D; Halangoda P
Australas Psychiatry; 2016 Dec; 24(6):602-603. PubMed ID: 27194777
[TBL] [Abstract][Full Text] [Related]
11. [A study of neuroleptic malignant syndrome in the presenium and senium].
Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
[TBL] [Abstract][Full Text] [Related]
12. [Neuroleptic malignant syndrome in users of risperidone].
Gerritsen AA; de Jonghe-Rouleau AP; Stienstra-Liem LH
Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1801-4. PubMed ID: 15495506
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome with risperidone.
Gleason PP; Conigliaro RL
Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotics leading to neuroleptic malignant syndrome in pregnancy.
Ghaffari N; Dossett E; Lee RH; Aghajanian P
Obstet Gynecol; 2012 Feb; 119(2 Pt 2):436-438. PubMed ID: 22270430
[TBL] [Abstract][Full Text] [Related]
15. High-dose vitamin E plus vitamin B6 treatment of risperidone-related neuroleptic malignant syndrome.
Dursun SM; Oluboka OJ; Devarajan S; Kutcher SP
J Psychopharmacol; 1998; 12(2):220-1. PubMed ID: 9694035
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
[TBL] [Abstract][Full Text] [Related]
17. Risperidone-induced neuroleptic malignant syndrome.
Sharma R; Trappler B; Ng YK; Leeman CP
Ann Pharmacother; 1996; 30(7-8):775-8. PubMed ID: 8826559
[TBL] [Abstract][Full Text] [Related]
18. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
[TBL] [Abstract][Full Text] [Related]
19. Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent.
Robb AS; Chang W; Lee HK; Cook MS
J Child Adolesc Psychopharmacol; 2000; 10(4):327-30. PubMed ID: 11191694
[TBL] [Abstract][Full Text] [Related]
20. Risperidone-induced neuroleptic malignant syndrome.
Bajjoka I; Patel T; O'Sullivan T
Ann Emerg Med; 1997 Nov; 30(5):698-700. PubMed ID: 9360586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
